Skip to main content

Table 3 Variables associated with OPM according to the logistic regression model

From: Establishment and verification of prediction model of occult peritoneal metastasis in advanced gastric cancer

Variable

Univariable analysis

Multivariable analysis

OR (95%CI)

P value

OR (95%CI)

P value

Age (%)

0.65 (0.23–1.87)

0.426

  

Sex (%)

1.13 (0.42–3.02)

0.803

  

BMI (%)

0.93 (0.17–5.15)

0.937

  

Clinical T stage (%)*

1.40 (0.48–4.11)

0.538

  

Clinical N stage (%)*

1.12 (0.21–6.05)

0.891

  

Neutrophil count (N)

0.76 (0.56, 1.04)

0.0902

  

Platelet count (P)

1.00 (0.99, 1.00)

0.5999

  

NLR

0.82 (0.61, 1.09)

0.1712

  

PLR

125.0 (90.9, 166.7)

0.5512

  

Hemoglobin (Hb)

0.99 (0.98, 1.01)

0.5182

  

Albumin (Alb)

0.95 (0.82, 1.10)

0.5181

  

AFP

1.04 (0.89, 1.23)

0.6057

  

CEA

1.00 (0.97, 1.03)

0.8507

  

CA125

1.08 (1.01, 1.16)

0.0098

1.11 (1.02, 1.20)

0.0123

CA242

1.00 (1.00, 1.01)

0.4783

  

CA199

1.00 (1.00, 1.00)

0.9661

  

CA724

1.01 (0.98, 1.03)

0.4865

  

Tumor location (%)

2.92 (0.91, 9.44)

0.0426

10.61 (1.34, 84.22)

0.254

Lauren classification (%)

0.21 (0.06, 0.75)

0.0163

0.40 (0.18, 0.88)

0.0219

CLDN18.2

0.86 (0.76, 0.97)

0.0169

0.86 (0.75, 0.99)

0.0301

Tumor differentiation type (%)

0.12 (0.01, 1.11)

0.0416

0.03 (0.00, 2.17)

0.1096

  1. *Refers to the clinical stage of the cancer (cTNM)
  2. NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio, CLDN18.2 Claudin18.2 in Gastric Endoscopic Biopsy Specimen Immunohistochemistry Score
  3. Note: Boldface indicates statistical significance (P <0.05)